Treatment Response in Individual Organs Affected by Chronic Graft-Versus-Host Disease

Chronic graft-versus-host disease (GVHD) occurs in 30–70% of patients after allogeneic hematopoietic cell transplantation (HCT) and increases the risks of morbidity and mortality. Systemic corticosteroids are the standard initial treatment, but one-third of patients require subsequent treatment with...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Takanobu Morishita, Paul J. Martin, Yoshihiro Inamoto
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2025-02-01
Edice:	Cells
Témata:	keyword allogeneic hematopoietic cell transplantation chronic graft-versus-host disease organ response extracorporeal photopheresis ibrutinib ruxolitinib
On-line přístup:	https://www.mdpi.com/2073-4409/14/4/238
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!